tiprankstipranks
GeneDx Holdings (WGS)
NASDAQ:WGS
US Market

GeneDx Holdings (WGS) Financial Statements

Compare
609 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently $3.10B. The company's EPS TTM is $2.872; its P/E ratio is 38.75; GeneDx Holdings is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 202.57M$ 234.69M$ 212.19M$ 179.32M
Gross Profit$ 60.62M$ -26.75M$ -16.60M$ 4.03M
Operating Income$ -163.66M$ -667.65M$ -446.15M$ -241.99M
EBITDA$ -136.46M$ -398.20M$ -219.19M$ -224.73M
Net Income$ -175.77M$ -548.98M$ -245.39M$ -246.44M
Balance Sheet
Cash & Short-Term Investments$ 130.15M$ 123.93M$ 400.57M$ 108.13M
Total Assets$ 473.67M$ 490.94M$ 554.09M$ 251.64M
Total Debt$ 119.77M$ 72.38M$ 32.85M$ 45.02M
Net Debt$ 20.09M$ -51.55M$ -367.72M$ -63.11M
Total Liabilities$ 245.66M$ 237.24M$ 165.99M$ 581.69M
Stockholders' Equity$ 228.02M$ 253.71M$ 388.10M$ -330.05M
Cash Flow
Free Cash Flow$ -185.86M$ -333.48M$ -211.22M$ -125.10M
Operating Cash Flow$ -180.15M$ -319.15M$ -190.43M$ -93.13M
Investing Cash Flow$ -43.73M$ -141.33M$ -20.79M$ -31.97M
Financing Cash Flow$ 186.24M$ 197.31M$ 493.73M$ 129.06M
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis